DMX-200 clinical trials

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

This study looks at a new drug, DMX-200, for people aged 12 to 80 with a kidney condition called FSGS. It aims to see if the drug is safe and helps prevent kidney damage when taken with another medicine called an ARB.